Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
Juan Montoro GómezElisa RoldánJosé Luis PiñanaPere BarbaPedro ChorãoAbdiel QuinteroRafael HernaniGuillermo OrtíJosé Ignacio LorenzoAitana Balaguer-RosellóOlga SalameroLaura FoxPilar SolvesInés GómezManuel GuerreiroJuan Carlos Hernández BoludaGuillermo SanzCarlos SolanoMiguel Ángel SanzDavid ValcárcelJaime SanzPublished in: European journal of haematology (2020)
PTCy-Sir-MMF provides better survival outcomes but is associated with higher risk of cGVHD compared to TCD.